 |
|
Effect of Treating Isolated Systolic Hypertension on the Risk of Developing Various Types and Subtypes of Stroke
The Systolic Hypertension in the Elderly Program (SHEP)
H. Mitchell Perry Jr, MD;
Barry R. Davis, MD, PhD;
Thomas R. Price, MD;
William B. Applegate, MD;
William S. Fields, MD;
Jack M. Guralnik, MD;
Lewis Kuller, MD;
Sara Pressel, MS;
Jeremiah Stamler, MD;
Jeffrey L. Probstfield, MD;
for the Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group
JAMA. 2000;284:465-471.
Context The Systolic Hypertension in the Elderly Program (SHEP) demonstrated that treating isolated systolic hypertension in older patients decreased incidence of total stroke, but whether all types of stroke were reduced was not evaluated.
Objective To investigate antihypertensive drug treatment effects on incidence of stroke by type and subtype, timing of strokes, case-fatality rates, stroke residual effects, and relationship of attained systolic blood pressure to stroke incidence.
Design The SHEP study, a randomized, double-blind, placebo-controlled trial began March 1, 1985, and had an average follow-up of 4.5 years.
Setting and Participants A total of 4736 men and women aged 60 years or older with isolated systolic hypertension at 16 clinical centers in the United States.
Interventions Patients were randomly assigned to receive treatment with 12.5 mg/d of chlorthalidone (step 1); either 25 mg/d of atenolol or 0.05 mg/d of reserpine (step 2) could be added (n = 2365); or placebo (n = 2371).
Main Outcome Measures Occurrence, type and subtype, and timing of first strokes and stroke fatalities; and change in stroke incidence for participants (whether in active treatment or placebo groups) reaching study-specific systolic blood pressure goal (decrease of at least 20 mm Hg from baseline to below 160 mm Hg) compared with participants not reaching goal.
Results A total of 85 and 132 participants in the active treatment and placebo groups, respectively, had ischemic strokes (adjusted relative risk [RR], 0.63; 95% confidence interval [CI], 0.48-0.82); 9 and 19 had hemorrhagic strokes (adjusted RR, 0.46; 95% CI, 0.21-1.02); and 9 and 8 had strokes of unknown type (adjusted RR, 1.05; 95% CI, 0.40-2.73), respectively. Four subtypes of ischemic stroke were observed in active treatment and placebo group participants, respectively, as follows: for lacunar, n = 23 and n = 43 (adjusted RR, 0.53; 95% CI, 0.32-0.88); for embolic, n = 9 and n = 16 (adjusted RR, 0.56; 95% CI, 0.25-1.27); for atherosclerotic, n = 13 and n = 13 (adjusted RR, 0.99; 95% CI, 0.46-2.15); and for unknown subtype, n = 40 and n = 60 (adjusted RR, 0.64; 95% CI, 0.43-0.96). Treatment effect was observed within 1 year for hemorrhagic strokes but was not seen until the second year for ischemic strokes. Stroke incidence significantly decreased in participants attaining study-specific systolic blood pressure goals.
Conclusions In this study, antihypertensive drug treatment reduced the incidence of both hemorrhagic and ischemic (including lacunar) strokes. Reduction in stroke incidence occurred when specific systolic blood pressure goals were attained.
Author Affiliations: Department of Medicine, Washington University, St Louis, Mo (Dr Perry); School of Public Health, University of Texas Health Science Center, Houston (Drs Davis and Fields and Ms Pressel); Department of Neurology, University of Maryland School of Medicine, Baltimore (Dr Price); Department of Medicine, Wake Forest University, Winston-Salem, NC (Dr Applegate); National Institute on Aging, Bethesda, Md (Dr Guralnik); Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pa (Dr Kuller); Department of Preventive Medicine, Northwestern University Medical School, Chicago, Ill (Dr Stamler); and Department of Medicine, University of Washington, Seattle (Dr Probstfield). A complete list of the SHEP Cooperative Research Group was published previously (JAMA. 1991;265:3255-3264).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
July 26, 2000
JAMA. 2000;284(4):505-506.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Something Subtle About Death: Isolated Systolic Pulmonary Pressure
Gomberg-Maitland
Circulation 2009;119:2647-2649.
FULL TEXT
Age-Associated Increases in Pulmonary Artery Systolic Pressure in the General Population
Lam et al.
Circulation 2009;119:2663-2670.
ABSTRACT
| FULL TEXT
Hypertension Subtype and Risk of Cardiovascular Disease in Chinese Adults
Kelly et al.
Circulation 2008;118:1558-1566.
ABSTRACT
| FULL TEXT
Prevention of Heart Failure: A Scientific Statement From the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group
Schocken et al.
Circulation 2008;117:2544-2565.
ABSTRACT
| FULL TEXT
Long-Term Fatal Outcomes in Subjects With Stroke or Transient Ischemic Attack: Fourteen-Year Follow-Up of the Systolic Hypertension in the Elderly Program
Patel et al.
Stroke 2008;39:1084-1089.
ABSTRACT
| FULL TEXT
REPRINT: Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults: 2007 Update: A Guideline From the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
Broderick et al.
Circulation 2007;116:e391-e413.
ABSTRACT
| FULL TEXT
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults: 2007 Update: A Guideline From the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
Broderick et al.
Stroke 2007;38:2001-2023.
ABSTRACT
| FULL TEXT
Abnormal Pressure Passive Dilatation of Cerebral Arterioles in the Elderly With Isolated Systolic Hypertension
Castellani et al.
Hypertension 2006;48:1143-1150.
ABSTRACT
| FULL TEXT
Blood Pressure Lowering for Primary and Secondary Prevention of Stroke
Zhang et al.
Hypertension 2006;48:187-195.
FULL TEXT
Decreasing incidence of lacunar vs other types of cerebral infarction in a Japanese population
Kubo et al.
Neurology 2006;66:1539-1544.
ABSTRACT
| FULL TEXT
Avoiding Central Nervous System Bleeding During Antithrombotic Therapy: Recent Data and Ideas
Hart et al.
Stroke 2005;36:1588-1593.
ABSTRACT
| FULL TEXT
Pharmacist Involvement in Primary Care Improves Hypertensive Patient Clinical Outcomes
Sookaneknun et al.
The Annals of Pharmacotherapy 2004;38:2023-2028.
ABSTRACT
| FULL TEXT
Management of Hypertension in the Very Elderly Patient
Elliott
Hypertension 2004;44:800-804.
ABSTRACT
| FULL TEXT
Left Ventricular Hypertrophy: The Next Treatable, Silent Killer?
Gardin and Lauer
JAMA 2004;292:2396-2398.
FULL TEXT
Secondary Prevention Strategies in Ischemic Stroke: Identification and Optimal Management of Modifiable Risk Factors
Flemming and Brown
Mayo Clin Proc. 2004;79:1330-1340.
ABSTRACT
Cerebroprotection mediated by angiotensin II: A hypothesis supported by recent randomized clinical trials
Fournier et al.
J Am Coll Cardiol 2004;43:1343-1347.
ABSTRACT
| FULL TEXT
Effects of a Perindopril-Based Blood Pressure-Lowering Regimen on the Risk of Recurrent Stroke According to Stroke Subtype and Medical History: The PROGRESS Trial
Chapman et al.
Stroke 2004;35:116-121.
ABSTRACT
| FULL TEXT
Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset
Oliveira-Filho et al.
Neurology 2003;61:1047-1051.
ABSTRACT
| FULL TEXT
Commentary
Lowenthal
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2003;58:M664-665.
FULL TEXT
Managing Hypertension in Patients With Stroke: Are You Prepared for Labetalol Infusion?
Harrington
Crit Care Nurse 2003;23:30-38.
FULL TEXT
Geographical variation in cardiovascular disease, risk factors, and their control in older women: British Women's Heart and Health Study
Lawlor et al.
J. Epidemiol. Community Health 2003;57:134-140.
ABSTRACT
| FULL TEXT
Hypertension control at hospital discharge after acute coronary event: influence on cardiovascular prognosis--the PREVENIR study
Amar et al.
Heart 2002;88:587-591.
ABSTRACT
| FULL TEXT
Isolated and Borderline Isolated Systolic Hypertension Relative to Long-Term Risk and Type of Stroke: A 20-Year Follow-Up of the National Health and Nutrition Survey
Qureshi et al.
Stroke 2002;33:2781-2788.
ABSTRACT
| FULL TEXT
New Evidence for Stroke Prevention: Scientific Review
Straus et al.
JAMA 2002;288:1388-1395.
ABSTRACT
| FULL TEXT
Effect of time since onset of risk factors on the occurrence of ischemic stroke
Whisnant et al.
Neurology 2002;58:787-794.
ABSTRACT
| FULL TEXT
Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy: An Invited Review
Gorelick
Stroke 2002;33:862-875.
ABSTRACT
| FULL TEXT
Healthy ageing: ageing safely
Buckley
Eur Heart J Suppl 2001;3:N6-N10.
ABSTRACT
Differences Between Primary vs Secondary Prevention Trials Regarding the Stroke Protective Effect of Antihypertensive Drugs
Fournier et al.
Arch Intern Med 2001;161:2152-2153.
FULL TEXT
Detection of Peripheral Arterial Disease in Primary Care
Ouriel
JAMA 2001;286:1380-1381.
FULL TEXT
Recurrent ischemia in symptomatic carotid occlusion: Prognostic value of hemodynamic factors
Dobkin et al.
Neurology 2001;57:161-162.
FULL TEXT
Longitudinal study of blood pressure and white matter hyperintensities: The EVA MRI Cohort
Dufouil et al.
Neurology 2001;56:921-926.
ABSTRACT
| FULL TEXT
|
